Mediwatch to Distribute Sonosite Products to UK Urology MarketSonosite Technology to be Incorporated into Mediwatch's Prostate Assessment ProductLONDON, September 2, 2004 - Sonosite Inc. (Nasdaq: SONO), the worldwide leader in high performance, hand-carried ultrasound, announced today that Sonosite, Ltd., the Company's United Kingdom (UK) subsidiary, has entered into two distribution and supply agreements with Mediwatch Plc., (LSE:MDW.L) a leading developer, manufacturer and distributor of advanced urological primary care products for the screening, diagnosis and assessment of urological disease and disorders. Under the terms of the first agreement, Mediwatch will become an authorised distributor of Sonosite's hand-carried ultrasound systems for the UK urology market. Pursuant to the second agreement, Sonosite will supply Mediwatch with its TITAN ultrasound technology to be incorporated into Mediwatch's proprietary 'One Stop' Prostate Assessment System, which is currently under development and Mediwatch intends to market worldwide when completed. Mediwatch's 'One Stop' Prostate Assessment System is designed to provide the physician with a complete system for the diagnosis and assessment of prostate health in the clinic and will include imaging, urinalysis and blood testing capabilities. … [Read more]
SEATTLE, September 10, 2004 - The Association for Corporate Growth, Seattle Chapter, announced today that it has awarded the ACG Seattle Regional Emerging Growth Award to Quinton Cardiology Systems, Inc. and Sonosite, Inc. The awards were presented at an ACG Seattle event at the Washington Athletic Club on September 8, 2004. Quinton CEO John Hinson and Sonosite CEO Kevin Goodwin spoke at the event, which was taped and televised on TVW - Washington State's Public Affairs Network.Every year the Association for Corporate Growth (ACG Global) presents the Outstanding Growth Award and the Emerging Company Award to two companies, honoring them for sustained excellence in corporate growth and financial performance. This year, for the very first time, ACG Seattle established a regional award and nominated two firms for the ACG Global Emerging Company Award.This award recognized companies for superior growth for at least the last three years, and is awarded to qualifying companies with revenues under $500 million in the most recent fiscal year.… [Read more]
US and Canada's Space Agencies Testing Medical Technology in Undersea Mission Harsh Conditions Simulate SpaceBOTHELL, WA and TORONTO - October 14, 2004 - Sonosite, (Nasdaq:SONO) the world's leader in hand-carried ultrasound, said today that TITAN, the company's compact, high performance system, will take part in a 10-day underwater experiment with NASA Extreme Environment Mission Operations (NEEMO) 7 Mission. Aquanauts will use the laptop-sized ultrasound system to scan each other in simulated emergency situations and transmit live images to St. Joseph's Healthcare in Hamilton, Ontario for review by radiologists. The NEEMO 7 mission to be conducted October 11-21, 2004 is a joint project involving the National Aeronautics and Space Administration (NASA), the Canadian Space Agency (CSA) and the Centre for Minimal Access Surgery (CMAS) at McMaster University of Hamilton, Ontario. The mission aims to demonstrate and evaluate a variety of medical diagnostic and therapeutic technologies to enhance the delivery of state-of-the-art medical care in remote and harsh environments. The experiments will take place off the coast of Key Largo, Fla, 19 meters below the surface of the sea in an underwater habitat called Aquarius. The extreme hostile environment is analogous to human space flight and has been used by NASA in the training of space station astronauts since 2001. … [Read more]
SEATTLE, WA - September 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in hand-carried ultrasound technology, joined today with leading medical societies in speaking out against the non-medical practice of "keepsake ultrasounds." "The AIUM and other medical societies have been very concerned that so called "entertainment or keepsake sonograms" performed outside a diagnostic facility with no medical supervision represent an inappropriate use of ultrasound technology and are contrary to responsible medical practice," said Lewis H. Nelson, III, MD, RDMS, president of the American Institute of Ultrasound in Medicine (AIUM). "We commend Sonosite for its support in discouraging the improper use of ultrasound technology." The AIUM is a leading accrediting body for medical ultrasound facilities and laboratories. The multidisciplinary organization represents over 9,000 medical professionals utilizing diagnostic ultrasound including radiologists, cardiologists, interventionalists, surgeons, vascular specialists, OB/Gyns, sonographers and scientists. Other medical societies expressing concern about the commercial, non-medical use of ultrasound are the American College of Obstetricians and Gynecologists (ACOG), the American College of Radiology (ACR) and the Society of Diagnostic Medical Sonography (SDMS). … [Read more]
Worldwide Quarterly Revenue Increases 44% Over Prior YearCompany Reports $0.09 EPSConference Call Today at 1:30 pm PT/4:30 ETBOTHELL, WA - October 28, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported financial results for the quarter ended September 30, 2004. Worldwide revenue in the third quarter of 2004 grew 44% to $29.1 million compared with $20.2 million in the third quarter of 2003. For the first nine months of 2004, the Company's total revenue grew 37% to $78.7 million compared with $57.5 million for the same period of the prior year. Year-over-year, changes in foreign currency rates increased the revenue growth rate by two percentage points for the third quarter and three percentage points for the first nine months of this year. Sonosite reported net income of $1.4 million, or $0.09 per diluted share, for the third quarter of 2004, compared with a net loss of $161,000, or $0.01 per share, in the third quarter of 2003. Year-to-date, Sonosite reported a net loss of $49,000, or breakeven on a per share basis, compared with a net loss of $4.0 million, or $0.28 per share, for the first nine months of 2003. … [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA - October 18, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its third quarter financial results on Thursday, October 28, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its third quarter performance, outlook for the rest of 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning October 28, 2004, 4:30 pm (PDT) until November 12, 2004, 12:00 midnight (PDT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code of 981261 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com. About Sonosite… [Read more]
Sonosite Introduces Technology for Early Risk Assessment of Cardiovascular DiseaseSoftware Detects Thickened Arterial Walls and Enables Doctors to Treat Patients at the Point of Care With More ConfidenceNEW ORLEANS, November 9, 2004 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today introduced SonoCalc IMT software, which allows physicians to effectively measure the intima-media thickness (IMT) of the carotid arteries and assess a patient's risk of cardiovascular disease early. The company made the announcement at the American Heart Association (AHA) Scientific Sessions 2004 in New Orleans, at which there are a number of clinical presentations addressing the benefits of IMT measurement for cardiovascular disease.Twenty years of clinical research has shown that the arterial wall lining or IMT of the carotid arteries becomes thickened years before plaque develops within the vessel. This increased wall thickness is associated with an increased risk of cardiovascular disease, the leading cause of mortality and disability in the United States today.… [Read more]
Sonosite Announces Fourth Major Upgrade for TITAN System at Leading Radiological Society Annual Meet
New Capabilities Added for Interventional Procedures and General ImagingWorldwide TITAN Installed Base Over 2,500… [Read more]
BOTHELL, WA - October 27, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the RBC Dain Rauscher Client Conference at the Seattle Sheraton on Thursday, November 4, 2004 at 08:35 am (PST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://ir.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About SonositeSonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
Sonosite Begins Customer Shipments of IMT Software for Early Risk Assessment of Cardiovascular Disea
Ultrasound-Based Software Allows Physicians to Measure Thickened Arterial WallsBOTHELL, WASH., December 29, 2004 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, said today that it has begun customer shipments of the SonoCalc IMT„¢ software, which allows physicians to quickly and effectively measure the wall thickness (IMT) of the common carotid arteries and assess a patient's risk of cardiovascular disease. Used in conjunction with the TITAN system - Sonosite's high-resolution, hand-carried ultrasound technology - the SonoCalc„¢ IMT software enables physicians to identify disease at an early stage and to manage it more effectively. The software, which is PC-based, works with digital images downloaded from the TITAN system. "The start of customer shipments of SonoCalc„¢ IMT signals the beginning of our move into what we believe is an emerging and potentially large preventive cardiology market," said Kevin M. Goodwin, president and CEO of Sonosite, Inc. "This technology offers physicians a low-cost and non-invasive means to identify cardiovascular disease early when it is both treatable and reversible.… [Read more]
BOTHELL, WASH., January 6, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the 23rd JPMorgan Healthcare Conference at the Westin St Francis in San Francisco on Thursday, January 13, 2005 at 1:30 pm (PST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days. About Sonosite… [Read more]
BOTHELL, WA, February 15, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the appointments of Anne M. Bugge as Vice President, Corporate Affairs and John M. Lowell, Vice President, Operations.
Ms. Bugge will have responsibility for developing and managing Sonosite's investor and corporate communications worldwide and will report to Kevin M. Goodwin, Sonosite President and CEO. Ms. Bugge served as Vice President, Corporate and Investor Relations for ATL Ultrasound, Inc. and its predecessor company, Westmark International, Inc. from 1987 until its acquisition by Philips Medical Systems in 1998. Most recently, Ms. Bugge worked with the EVC Group, an investor and corporate communications firm specializing in advising small cap companies. Ms. Bugge received a BA in journalism from Michigan State University, continued academic studies at the University of Oslo and completed the Stanford University Executive Program.
As Vice President, Operations, Mr. Lowell's primary responsibilities will focus on directing manufacturing operations, supplier management and information technology functions at Sonosite and will report to Bradley G. Garrett, Sonosite's Chief Operating Officer. Mr. Lowell has an extensive background in engineering and operations management in the high technology field. Mr.… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA, February 3, 2005 €“ Sonosite, Inc. (Nasdaq: SONO) today announced that the Company will report its fourth quarter and 2004 year-end financial results on Tuesday, February 15, 2005 after the market close. Sonosite's management team will host a conference call on Tuesday, February 15, 2005 at 1:30 pm (PST)/4:30 pm (EST) to discuss the Company's fourth quarter and year-end results. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com.A replay of the audio webcast will be available beginning February 15, 2005, 4:30 pm (PST) until February 28, 2005, 12:00 midnight (PST) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code 5110974 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/.About Sonosite… [Read more]
BOTHELL, January 28, 2004 - Sonosite, Inc. (NASDAQ: SONO), the leader in high-performance, hand-carried ultrasound technology, today announced the appointment of Robert G. Hauser, M.D., F.A.C.C., president, Cardiovascular Services Division of Abbot Northwestern Hospital, to its board of directors."We are delighted that Dr. Hauser, a prominent cardiologist and accomplished executive, has joined our board," said Kevin M. Goodwin, president and CEO of Sonosite. "Dr. Hauser's broad business experience and expertise in cardiovascular medicine will play a crucial role in advising the company on growth strategies as we extend our technology and sales efforts further into key markets."In addition to his position as president of the Cardiovascular Services Division at Abbot Northwestern, Dr. Hauser, 64, is a senior consulting cardiologist at the Minneapolis Heart Institute. He was formerly the director of Pacemaker Surveillance Clinic, Minneapolis Heart Institute and served as president of the Minneapolis Heart Institute. Prior to that, Dr. Hauser served as chief executive officer of Minneapolis Cardiology Associates. He also served as president and chief executive officer of Cardiac Pacemakers, Inc. from 1988 to 1991, and continued as its Chairman and CEO until 1992 following its acquisition by Guidant.… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, January 28, 2004 - Sonosite, Inc. (NASDAQ: SONO) today announced that the Company will report its fourth quarter and 2003 year-end financial results on Thursday, February 12, 2004 after the market close. Sonosite's management team will host a conference call on Thursday, February 12, 2004 at 1:30 pm (PST)/4:30 pm (EST) to discuss the Company's fourth quarter and year-end results. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com.A replay of the audio webcast will be available beginning February 12, 2004, 4:30 pm (PST) until February 26, 2004, 12:00 midnight (PST) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code 461061 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite… [Read more]
Fourth Quarter revenue increases to $27.3 millionFourth quarter profitability grows to $2.2 million or $0.15/shareSubsidiaries to open in Japan, Australia and CanadaBOTHELL, WA, February 12, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue, gross margin and net income for the fourth quarter ended December 31, 2003 as compared with the fourth quarter of 2002.Revenue in the fourth quarter of 2003 grew to $27.3 million, a 9 percent increase over the fourth quarter of 2002. For the full year 2003, revenue increased 16 percent to $84.8 million compared with $73.0 million in 2002.The Company reported that net income increased 158 percent to $2.2 million or $0.15 per share for the fourth quarter of 2003 compared with $0.9 million or $0.06 per share in the prior year quarter. For the full year 2003, Sonosite reported a net loss of $1.8 million or $0.12 per share versus a net loss of $7.7 million or $0.59 per share for 2002. As of December 31, 2003, cash, cash equivalents and investments totaled $61.0 million.… [Read more]
Revenues Increase 33.6 Percent Worldwide and Gross Margins Rise for the Ninth Consecutive Quarter to 62.9 Percent
BOTHELL, WA, April 30, 2003 - Sonosite, Inc. (Nasdaq: SONO), the leader in point-of-care ultrasound, today released financial results for the first quarter ended March 31, 2003. In comparison to the first quarter of 2002, Sonosite reported a solid increase in revenues and increasing gross margins. Along with these financial results, in early April the Company launched its newest product, the TITAN high-resolution modular ultrasound system.
For the quarter, Sonosite reported revenues of $17.2 million compared to $12.8 million for the first quarter of 2002, an increase of 33.6 percent. Sonosite reported a net loss of $2.6 million, or $0.18 per share, for the quarter. This compared to a net loss of $3.7 million, or $0.32 per share for the comparable quarter in the prior year.
Gross margins increased for the ninth consecutive quarter to 62.9 percent, compared to 58.0 percent in the first quarter of 2002, and 60.3 percent in the fourth quarter of 2002. Gross margins rose as a result of a stronger mix from direct sales and advanced product configurations. As of March 31, 2003, cash, cash equivalents and investment securities totaled $64.9 million.… [Read more]
Upgrade Provides Complete Capabilities for Echo Studies;Addresses $460 Million International Shared Services Market… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA, July 16, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that the Company will report its second quarter financial results on Thursday, July 29, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its second quarter performance, outlook for 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning July 29, 2004, 4:30 pm (PDT) until August 13, 2004, 12:00 midnight (PDT) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code (589270) is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite… [Read more]
Company Begins to Regain Momentum in JapanWorldwide Sales and Marketing Executive Team StrengthenedBOTHELL, WA, April 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue and a reduced loss for the first quarter ended March 31, 2004 as compared with the first quarter of 2003. Worldwide revenue in the first quarter of 2004 grew 37% to $23.5 million compared to $17.2 million in the first quarter of 2003. The Company reported a net loss of $1.4 million or $0.10 per share for the quarter compared to a net loss of $2.6 million or $0.18 per share in the first quarter of 2003. As of March 31, 2004, cash, cash equivalents and investments grew to $64.1 million. The Company generated cash from operations of $2.8 million. … [Read more]